Form4insider filings, from the source

SEC Form 4 · accession 0001609351-18-000063

Spark Therapeutics, Inc. · ONCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Anand Mehra
Director
Period of report
May 30, 2018
Accepted (ET)
Jun 1, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 31, 2018M1,500—A1,500D
Common StockF2holding———481,270ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3$81.53May 30, 2018A4,000A—May 29, 2028Common Stock4,0004,000D
Restricted Stock UnitsF4,F5—May 30, 2018A1,500A——Common Stock1,5001,500D
Restricted Stock UnitsF4,F6—May 31, 2018M1,500D——Common Stock1,5000D

Explanation of responses